| 000 | 01340 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513065513.0 | ||
| 264 | 0 | _c19931129 | |
| 008 | 199311s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLarach, D R | |
| 245 | 0 | 0 |
_aPotassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cOct 1993 |
||
| 300 |
_a72-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzopyrans _xpharmacology |
| 650 | 0 | 4 |
_aCoronary Vessels _xdrug effects |
| 650 | 0 | 4 | _aCromakalim |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aGlyburide _xpharmacology |
| 650 | 0 | 4 |
_aHalothane _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 | _aPotassium Channel Blockers |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTetraethylammonium Compounds _xpharmacology |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aSchuler, H G | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 267 _gno. 1 _gp. 72-81 |
|
| 999 |
_c8229073 _d8229073 |
||